no chance unfortunately. We will have to wait until June.
Those more cautious may miss the initial rocket - but at least we will know it will be sustained then if they are able to replicate this data in a trial. Until then it is a small sample that is a indicator for a broader trial, mixed in with no clarity on the underlying health conditions of the 12 (if any) or certainty around the broader population survival rates (which we now know from the clarification over the weekend is likely to be much higher than 12%) .
Cell Therapy News/Articles, page-1942
-
- There are more pages in this discussion • 16,498 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5951 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 133644 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |